Cell Therapeutics Down 15.9% Since SmarTrend's Sell Recommendation
Do you know when to trade CTIC ?
CTIC | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Cell Therapeutics (NASDAQ:CTIC) on September 25, 2009 at $1.18.
Since then, Cell Therapeutics has returned 15.9% as of today's recent price of $0.99. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Cell Therapeutics Inc (CTIC) CTIC. Cell Therapeutics Inc (CTIC) has Short Term PowerRatings at TradingMarkets. Details on Cell Therapeutics Inc (CTIC) Short Term PowerRatings is available at This Link.
- Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Cell Therapeutics, Inc., Announces Class Action Lawsuit a - 03/19/10
- Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Fuqi International, Inc., Announces Class Action Lawsuit - 03/19/10
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Cell Therapeutics, Inc. - 03/19/10
- BioPharma Stock Alert for Cell Therapeutics Inc. Issued by BeaconEquity - 03/17/10
- Robbins Umeda LLP Announces Investigation of Cell Therapeutics, Inc. - 03/16/10
- More News >>


